Cargando…

Advances in Infectious Disease Vaccine Adjuvants

Vaccines are one of the most significant medical interventions in the fight against infectious diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the worldwide transmission to eradication levels of infectious diseases, including smallpox, diphtheria, hepatitis, malaria,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Jingyi, Jin, Shengbin, Gilmartin, Lachlan, Toth, Istvan, Hussein, Waleed M., Stephenson, Rachel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316175/ https://www.ncbi.nlm.nih.gov/pubmed/35891284 http://dx.doi.org/10.3390/vaccines10071120

Ejemplares similares

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
por: Zhang, Jiahui, et al.
Publicado: (2022)

Schistosome Vaccine Adjuvants in Preclinical and Clinical Research
por: Stephenson, Rachel, et al.
Publicado: (2014)

Recent Advances of Vaccine Adjuvants for Infectious Diseases
por: Lee, Sujin, et al.
Publicado: (2015)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines
por: Hussein, Waleed M., et al.
Publicado: (2016)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
por: Yang, Jing-Xing, et al.
Publicado: (2022)

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
por: Shalash, Ahmed O., et al.
Publicado: (2021)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease
por: Lim, Yong Taik
Publicado: (2015)

THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
por: Retnakumar, Sruthi Vijaya, et al.
Publicado: (2023)

Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
por: Rapaka, Rekha R., et al.
Publicado: (2021)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action
por: Wilson, Heather L., et al.
Publicado: (2021)

Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus
por: Kiong, Jolynn, et al.
Publicado: (2022)

Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases
por: Torres-Sangiao, Eva, et al.
Publicado: (2016)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

The advances of adjuvants in mRNA vaccines
por: Xie, Chunyuan, et al.
Publicado: (2023)

Progress in the Development of Subunit Vaccines against Malaria
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021)

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine
por: Yao, Yiyang, et al.
Publicado: (2023)

Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffold
por: Fagan, Vincent, et al.
Publicado: (2014)

Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein
por: Dai, Chuankai, et al.
Publicado: (2020)

Advances in mRNA Vaccines for Infectious Diseases
por: Zhang, Cuiling, et al.
Publicado: (2019)

Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
por: Moni, Sivakumar S., et al.
Publicado: (2023)

Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
por: Grunwald, Thomas, et al.
Publicado: (2015)

Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens
por: Islam, Md. Tanjir, et al.
Publicado: (2022)

Noninvasive vaccination against infectious diseases
por: Zheng, Zhichao, et al.
Publicado: (2018)

New perspectives for mesenchymal stromal cells as an adjuvant therapy for infectious disease-associated encephalopathies
por: Lima, Maiara N., et al.
Publicado: (2021)

Immunotherapy and vaccination against infectious diseases
por: Ebbers, Meinolf, et al.
Publicado: (2020)

Recent advances in the discovery and delivery of vaccine adjuvants
por: O'Hagan, Derek T., et al.
Publicado: (2003)

The Age of Cyclic Dinucleotide Vaccine Adjuvants
por: Gogoi, Himanshu, et al.
Publicado: (2020)

Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus
por: Faruck, Mohammad Omer, et al.
Publicado: (2020)

Recent advances in immunotherapies against infectious diseases
por: Ramamurthy, Dharanidharan, et al.
Publicado: (2020)

Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus
por: Zhao, Lili, et al.
Publicado: (2020)

Recent advances and challenges in electrochemical biosensors for emerging and re-emerging infectious diseases
por: Menon, Shalini, et al.
Publicado: (2020)

Adjuvants for COVID-19 Vaccines
por: Castrodeza-Sanz, Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ce8tvtn93im0lhmponil621c7q